SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009262
Filing Date
2023-05-11
Accepted
2023-05-11 07:30:46
Documents
95
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20230331x10q.htm   iXBRL 10-Q 1582935
2 EX-10.1 ipsc-20230331xex10d1.htm EX-10.1 77137
3 EX-10.2 ipsc-20230331xex10d2.htm EX-10.2 67016
4 EX-31.1 ipsc-20230331xex31d1.htm EX-31.1 13626
5 EX-31.2 ipsc-20230331xex31d2.htm EX-31.2 13440
6 EX-32.1 ipsc-20230331xex32d1.htm EX-32.1 6975
7 EX-32.2 ipsc-20230331xex32d2.htm EX-32.2 6943
  Complete submission text file 0001558370-23-009262.txt   8300572

Data Files

Seq Description Document Type Size
8 EX-101.SCH ipsc-20230331.xsd EX-101.SCH 63751
9 EX-101.CAL ipsc-20230331_cal.xml EX-101.CAL 67647
10 EX-101.DEF ipsc-20230331_def.xml EX-101.DEF 236202
11 EX-101.LAB ipsc-20230331_lab.xml EX-101.LAB 544656
12 EX-101.PRE ipsc-20230331_pre.xml EX-101.PRE 429889
89 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20230331x10q_htm.xml XML 1468024
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 23908836
SIC: 2836 Biological Products, (No Diagnostic Substances)